Saudi Arabia
· Delayed Price · Currency is SAR Dallah Healthcare Company Statistics
Total Valuation
Dallah Healthcare Company has a market cap or net worth of SAR 15.50 billion. The enterprise value is 17.62 billion.
| Market Cap | 15.50B |
| Enterprise Value | 17.62B |
Important Dates
The next estimated earnings date is Thursday, March 20, 2025.
| Earnings Date | Mar 20, 2025 |
| Ex-Dividend Date | Nov 18, 2024 |
Share Statistics
Dallah Healthcare Company has 97.38 million shares outstanding. The number of shares has increased by 2.30% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 97.38M |
| Shares Change (YoY) | +2.30% |
| Shares Change (QoQ) | -0.18% |
| Owned by Insiders (%) | 9.69% |
| Owned by Institutions (%) | 4.02% |
| Float | 40.36M |
Valuation Ratios
The trailing PE ratio is 33.00 and the forward PE ratio is 30.38. Dallah Healthcare Company's PEG ratio is 1.44.
| PE Ratio | 33.00 |
| Forward PE | 30.38 |
| PS Ratio | 4.85 |
| PB Ratio | 4.54 |
| P/TBV Ratio | 4.82 |
| P/FCF Ratio | 43.16 |
| P/OCF Ratio | n/a |
| PEG Ratio | 1.44 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 23.38, with an EV/FCF ratio of 49.05.
| EV / Earnings | 37.42 |
| EV / Sales | 5.50 |
| EV / EBITDA | 23.38 |
| EV / EBIT | 28.53 |
| EV / FCF | 49.05 |
Financial Position
The company has a current ratio of 1.11, with a Debt / Equity ratio of 0.55.
| Current Ratio | 1.11 |
| Quick Ratio | 0.79 |
| Debt / Equity | 0.55 |
| Debt / EBITDA | 2.82 |
| Debt / FCF | 5.67 |
| Interest Coverage | 5.57 |
Financial Efficiency
Return on equity (ROE) is 13.95% and return on invested capital (ROIC) is 6.61%.
| Return on Equity (ROE) | 13.95% |
| Return on Assets (ROA) | 5.77% |
| Return on Invested Capital (ROIC) | 6.61% |
| Return on Capital Employed (ROCE) | 11.11% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.50 |
| Inventory Turnover | 8.65 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -5.17% in the last 52 weeks. The beta is 0.21, so Dallah Healthcare Company's price volatility has been lower than the market average.
| Beta (5Y) | 0.21 |
| 52-Week Price Change | -5.17% |
| 50-Day Moving Average | 154.33 |
| 200-Day Moving Average | 159.32 |
| Relative Strength Index (RSI) | 61.22 |
| Average Volume (20 Days) | 69,656 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Dallah Healthcare Company had revenue of SAR 3.20 billion and earned 470.95 million in profits. Earnings per share was 4.82.
| Revenue | 3.20B |
| Gross Profit | 1.15B |
| Operating Income | 586.15M |
| Pretax Income | 512.33M |
| Net Income | 470.95M |
| EBITDA | 697.92M |
| EBIT | 586.15M |
| Earnings Per Share (EPS) | 4.82 |
Balance Sheet
The company has 208.22 million in cash and 2.04 billion in debt, giving a net cash position of -1.83 billion or -18.78 per share.
| Cash & Cash Equivalents | 208.22M |
| Total Debt | 2.04B |
| Net Cash | -1.83B |
| Net Cash Per Share | -18.78 |
| Equity (Book Value) | 3.70B |
| Book Value Per Share | 35.07 |
| Working Capital | 138.32M |
Cash Flow
In the last 12 months, operating cash flow was 779.46 million and capital expenditures -420.21 million, giving a free cash flow of 359.25 million.
| Operating Cash Flow | 779.46M |
| Capital Expenditures | -420.21M |
| Free Cash Flow | 359.25M |
| FCF Per Share | 3.69 |
Margins
Gross margin is 35.99%, with operating and profit margins of 18.30% and 14.70%.
| Gross Margin | 35.99% |
| Operating Margin | 18.30% |
| Pretax Margin | 16.00% |
| Profit Margin | 14.70% |
| EBITDA Margin | 21.79% |
| EBIT Margin | 18.30% |
| FCF Margin | 11.22% |
Dividends & Yields
This stock pays an annual dividend of 1.50, which amounts to a dividend yield of 0.94%.
| Dividend Per Share | 1.50 |
| Dividend Yield | 0.94% |
| Dividend Growth (YoY) | 33.33% |
| Years of Dividend Growth | 1 |
| Payout Ratio | 41.44% |
| Buyback Yield | -2.30% |
| Shareholder Yield | -1.36% |
| Earnings Yield | 3.04% |
| FCF Yield | 2.32% |
Stock Splits
The last stock split was on September 14, 2020. It was a forward split with a ratio of 1.2.
| Last Split Date | Sep 14, 2020 |
| Split Type | Forward |
| Split Ratio | 1.2 |
Scores
Dallah Healthcare Company has an Altman Z-Score of 4.46.
| Altman Z-Score | 4.46 |
| Piotroski F-Score | n/a |